Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Genovis AB (publ.)

GENO
Current price
27.3 SEK +0.8 SEK (+3.02%)
Last closed 26.5 SEK
ISIN SE0002485979
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 1 775 520 599 SEK
Yield for 12 month -36.51 %
1Y
3Y
5Y
10Y
15Y
GENO
21.11.2021 - 28.11.2021

Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics for customers in the pharmaceutical and research industries. The company provides FabALACTICA, a cysteine protease; FabRICATOR, a cysteine protease; and FabRICATOR Z, for the digestion of mouse IgG2a and IgG3, and generating a homogenous pool of F(ab')2 and Fc fragments. It offers FabULOUS (SpeB), a cysteine protease; GingisKHAN, a cysteine protease; FabDELLO, a protease that digests human IgG1; IgASAP, an IgA-digesting enzyme; and IgMBRAZOR, an IgM-specific protease. In addition, the company offers GingisREX, a protease that digests proteins C-terminally of arginine residues; GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers; GlyCLICK, a conjugation technology; TransGLYCIT, a platform technology; OmniGLYZOR, a mixture of immobilized enzymes; PNGase F, a glycoamidase; and OpeRATOR, an O-glycan-specific protease. Further, it provides OglyZOR, an endoglycosidase; SialEXO, a sialidase product; FucosEXO, a mix of a-Fucosidases; GalactEXO, a ß-Galactosidase mix; GalNAcEXO, an a-N-Acetylgalactosaminidase; GlycOCATCH, an affinity resin; GlycINATOR (EndoS2), an IgG-specific endoglycosidase; IgGZERO (EndoS), an IgG-specific endoglycosidase; Anti-FabRICATOR (Anti-IdeS), a goat polyclonal antibody; and Anti-FabRICATOR Z (Anti-IdeZ), a goat polyclonal antibody. Additionally, the company offers antibodies, assay kits, reagents, and cell culture products; bioprocess and gene therapy services; and services, such as SmartEnzymes fragmentation and conjugation, antibody LC-MS analysis, and customized antibody services, as well as operates an online store for its products. It serves pharmaceutical and biotech, contract research, and contract manufacturing companies in Europe, North America, and Asia. The company was founded in 1999 and is headquartered in Kävlinge, Sweden. Address: Box 4, Kävlinge, Sweden, 244 21

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

417.7 SEK

P/E ratio

102.8846

Dividend Yield

Current Year

+160 428 835 SEK

Last Year

+103 808 408 SEK

Current Quarter

+29 879 157 SEK

Last Quarter

+40 613 137 SEK

Current Year

+54 750 736 SEK

Last Year

+88 581 564 SEK

Current Quarter

+2 535 721 SEK

Last Quarter

+14 773 302 SEK

Key Figures GENO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 30 867 693 SEK
Operating Margin TTM 8.49 %
PE Ratio 102.8846
Return On Assets TTM 6.03 %
PEG Ratio
Return On Equity TTM 8.75 %
Wall Street Target Price 417.7 SEK
Revenue TTM 129 631 109 SEK
Book Value 2.96 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 89 772 806 SEK
Earnings per share 0.26 SEK
Diluted Eps TTM 0.26 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -88.2 %
Profit Margin 13.49 %

Dividend Analytics GENO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GENO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 04.04.2012
Dividend Date

Stock Valuation GENO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 102.8846
Forward PE
Enterprise Value Revenue 12.7709
Price Sales TTM 13.0311
Enterprise Value EBITDA 42.8
Price Book MRQ 8.0245

Financials GENO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GENO

For 52 weeks

19.26 SEK 54.65 SEK
50 Day MA 23.79 SEK
Shares Short Prior Month
200 Day MA 31.24 SEK
Short Ratio
Shares Short
Short Percent